I never shared this roadmap before. So Iâm putting it here. Most advice sounds good. Few actually work. People say: âLearn tools.â âCopy portfolios.â âChase titles.â Thatâs not how growth happens. This infographic exists because: Most designers feel stuck. Not untalented. Just misdirected. Real UX growth is quiet. It starts with: Curiosity. Practice. Taste. Then comes the hard part: Principles over pixels. Psychology over opinions. Process over trends. Then pressure shows up. Real projects. Messy problems. Daily reps. No shortcuts. Your portfolio becomes your system. Decision-making. Not decoration. Impact. Outcomes. Roles evolve naturally: Junior â Execution. Mid â Research + Communication. Senior â Strategy + Leadership. Lead isnât a title. Itâs earned trust. If youâre serious about UI/UX: Save this. Use it as a mirror. Build slowly. Built with lessons from real work at Musemind - Global UX Design Agency. PS: The right roadmap wonât hype you. It will compound you.
Career Roadmap Creation
Explore top LinkedIn content from expert professionals.
-
-
hims & hers cut Meta creative by 60% this quarter. Heres what we can learn from a DTC giant. Here's what's happening and what it teaches about organizing creative around new verticals: ð The data: -> Peak creative launch: ~1,000 ads (July 2025) -> Current launch rate: ~400 ads (November 2025) -> Marketing spend: down from 45% to 39% of revenue -> Subscriber growth: still 21% YoY So what changed? Their core business is being restructured. And they are adjusting creative around it. - September 2025: Low Testosterone -> 20 million men in the U.S. market - October 2025: Menopause & Perimenopause -> Hers proj $1B by 2026 - November 2025: Labs (Diagnostics) -> $199-$499/year plans - Also Q3-Q4 2025: International via Zava acquisition -> UK, Germany, France, Ireland, Spain, Canada Each of these needs its own creative discovery phase. Phase 1: Discovery (High Volume, Low Spend) Goal: Find what works before you scale. -> Launch 50-100 concepts across formats -> Test hooks, angles, audiences simultaneously -> Cap spend per ad ($500-1K max) -> Kill anything above target CPA fast -> Track slugging rate: what % of ads hit $5K+ spend? At this phase, you're buying data, not customers. If your slugging rate is under 10%, you have a messaging problem. If it's 20%+, you've found something. Phase 2: Validation (Medium Volume, Medium Spend) Goal: Confirm winners scale. -> Take your top 10-15% of concepts -> Test variations: same hook, different creator. Same creator, different hook. -> Push winning ads to $10K-50K spend -> Watch for CPA creep at 2x, 5x, 10x spend levels Most ads that work at $1K don't work at $50K. This phase finds the ones that do. Phase 3: Optimization (Low Volume, High Spend) Goal: Maximize efficiency from proven winners. -> Your top 1-2% of ads should drive 50%+ of spend -> Production shifts to iterations, not net new concepts -> Focus on extending lifespan, not replacing inventory -> Track Creative Churn Rate Hims is in Phase 3 for weight loss. Their GLP-1 creative is mature. They're simultaneously in Phase 1 for testosterone, menopause, and diagnostics. Brands try to run Phase 1 and Phase 3 with the same ideas and systems and it doesn't work. They either: -> Over-spend on new concepts that haven't proven scale OR -> Under-invest in testing because "we already know what works" Separate your creative roadmap by vertical maturity. Mature verticals: -> 70% optimization, 30% testing -> Focus on extending winners -> Production = Building on what works New verticals: -> 10% optimization, 90% testing -> High volume, low spend per concept -> Production = net new concepts hims & hers is pulling back volume on weight loss (mature) while ramping discovery on testosterone, menopause, and diagnostics (new). Their total ad count is down. But once they find a scalable vertical expect them to iterate and lean back in.
-
Weâre entering an era of creative abundance (some people would say weâre already in the era of creative abundance). AI tools can now generate thousands of ad variations, visuals, and messages in seconds. I really believe the real challenge is not just in generating more creatives, but creating smarter creatives. Smart creatives should be self-sufficient, context-aware, and designed to learn from performance and not just exist in isolation. Whether that is text ads, image ads or video ads, the fundamental performance metric of creatives doesnât change in terms of generating meaningful engagement with the right audience. Iâve been mapping a creative optimization framework around how I think about AI-generated creatives - not just as a production roadmap, but as part of a continuous system of intelligence. As part of my AIxM series, I designed the AIxM Creative Optimization Framework as a strategic model for how marketing teams can think about and design their AI-powered creative strategy (specifically not as a linear workflow, but as a continuous system). The model brings together creativity, performance, and intelligence in a closed loop: Analyze: AI interprets audience signals, behavior, and performance data to surface actionable insights Generate: AI produces adaptive creative concepts, messaging, and formats aligned to those insights Activate: Marketing systems dynamically deploy and personalize creatives across channels and placements Optimize: AI learns from performance data and feeds intelligence back into the system to continuously improve future creatives Whether youâre a lean team managing multiple campaigns or building an autonomous creative engine at scale, I hope this model helps marketing teams architect how AI supports creative decision-making, making creativity continuous, intelligence-driven, and measurably tied to performance. Follow me (Abhinav Prathivadi) for more from my AIxM Series, exploring AI+Marketing frameworks that connect intelligence, creativity, and performance to drive marketing impact at scale. I also write a newsletter, The Leadership Advantage, sharing practical insights on AI, leadership, and navigating work in an AI-first world (subscribe link in the bio).